dc.contributor.author | Pehkonen, Jaakko | |
dc.contributor.author | Viinikainen, Jutta | |
dc.contributor.author | Kari, Jaana T. | |
dc.contributor.author | Böckerman, Petri | |
dc.contributor.author | Lehtimäki, Terho | |
dc.contributor.author | Viikari, Jorma | |
dc.contributor.author | Raitakari, Olli | |
dc.date.accessioned | 2021-12-20T12:11:09Z | |
dc.date.available | 2021-12-20T12:11:09Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Pehkonen, J., Viinikainen, J., Kari, J. T., Böckerman, P., Lehtimäki, T., Viikari, J., & Raitakari, O. (2022). Birth weight, adult weight, and cardiovascular biomarkers : Evidence from the Cardiovascular Young Finns Study. <i>Preventive Medicine</i>, <i>154</i>, Article 106894. <a href="https://doi.org/10.1016/j.ypmed.2021.106894" target="_blank">https://doi.org/10.1016/j.ypmed.2021.106894</a> | |
dc.identifier.other | CONVID_102952828 | |
dc.identifier.uri | https://jyx.jyu.fi/handle/123456789/79045 | |
dc.description.abstract | This study quantifies the causal effect of birth weight on cardiovascular biomarkers in adulthood using the Cardiovascular Risk in Young Finns Study (YFS). We apply a multivariable Mendelian randomization (MVMR) method that provides a novel approach to improve inference in causal analysis based on a mediation framework. The results show that birth weight is linked to triglyceride levels (β = −0.294; 95% CI [−0.591, 0.003]) but not to low-density lipoprotein (LDL) cholesterol levels (β = 0.007; 95% CI [−0.168, 0.183]). The total effect of birth weight on triglyceride levels is partly offset by a mediation pathway linking birth weight to adult BMI (β = 0.111; 95% CI [−0.013, 0.234]). The negative total effect is consistent with the fetal programming hypothesis. The positive indirect effect via adult BMI highlights the persistence of body weight throughout a person's life and the adverse effects of high BMI on health. The results are consistent with previous findings that both low birth weight and weight gain increase health risks in adulthood. | en |
dc.format.mimetype | application/pdf | |
dc.language.iso | eng | |
dc.publisher | Elsevier BV | |
dc.relation.ispartofseries | Preventive Medicine | |
dc.rights | CC BY-NC-ND 4.0 | |
dc.subject.other | causal mediation | |
dc.subject.other | multivariable Mendelian randomization | |
dc.subject.other | birth weight | |
dc.subject.other | adult BMI | |
dc.subject.other | triglycerides | |
dc.subject.other | LDL cholesterol | |
dc.title | Birth weight, adult weight, and cardiovascular biomarkers : Evidence from the Cardiovascular Young Finns Study | |
dc.type | article | |
dc.identifier.urn | URN:NBN:fi:jyu-202112206028 | |
dc.contributor.laitos | Kauppakorkeakoulu | fi |
dc.contributor.laitos | School of Business and Economics | en |
dc.contributor.oppiaine | Empirical Microeconomics | fi |
dc.contributor.oppiaine | Taloustiede | fi |
dc.contributor.oppiaine | Päätöksentekoa tukeva taloustiede ja talouden kilpailukyky (painoala) | fi |
dc.contributor.oppiaine | Basic or discovery scholarship | fi |
dc.contributor.oppiaine | Empirical Microeconomics | en |
dc.contributor.oppiaine | Economics | en |
dc.contributor.oppiaine | Policy-Relevant Economics and Competitiveness of Economy (focus area) | en |
dc.contributor.oppiaine | Basic or discovery scholarship | en |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | |
dc.type.coar | http://purl.org/coar/resource_type/c_2df8fbb1 | |
dc.description.reviewstatus | peerReviewed | |
dc.relation.issn | 0091-7435 | |
dc.relation.volume | 154 | |
dc.type.version | publishedVersion | |
dc.rights.copyright | © 2021 the Authors | |
dc.rights.accesslevel | openAccess | fi |
dc.subject.yso | triglyseridit | |
dc.subject.yso | monimuuttujamenetelmät | |
dc.subject.yso | syntymäpaino | |
dc.subject.yso | painoindeksi | |
dc.subject.yso | kausaliteetti | |
dc.subject.yso | sydän- ja verisuonitaudit | |
dc.subject.yso | biomarkkerit | |
dc.subject.yso | LDL-kolesteroli | |
dc.subject.yso | geneettiset tekijät | |
dc.format.content | fulltext | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p23740 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p2131 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p21306 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p21142 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p333 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p9886 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p12288 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p14054 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p21661 | |
dc.rights.url | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.relation.doi | 10.1016/j.ypmed.2021.106894 | |
jyx.fundinginformation | The YFS has been financially supported by the Academy of Finland (grant numbers 322098, 286284, 134309 (Eye), 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi), 41071 (Skidi)); Social Insurance Institution of Finland; Competitive State Research Financing of the Expert Responsibility area of Kuopio; Tampere and Turku University Hospitals (grant number X51001); Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation; the Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjö Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Jenny and Antti Wihuri Foundation; Diabetes Research Foundation of Finnish Diabetes Association; EU Horizon 2020 (grant number 755320 for TAX-INOMISIS); European Research Council (grant number 742927 for MULTIEPIGEN project); Tampere University Hospital Supporting Foundation; the Society of Finnish Clinical Chemistry. | |
dc.type.okm | A1 | |